Appearance is first for a Chinese ultrasound companyShantou Institute of Ultrasonic Instruments scored a historicfirst at last month's Radiological Society of North America exhibitionby becoming the first ultrasound equipment manufacturer
Shantou Institute of Ultrasonic Instruments scored a historicfirst at last month's Radiological Society of North America exhibitionby becoming the first ultrasound equipment manufacturer basedin China to promote its products at the annual show.
An SIUI delegation headed by Yao Jinzhong, the institute'sfounder and president, came to Chicago to display its productline, which has been submitted to the Food and Drug Administrationfor 510(k) review. The company also seeks cooperation from radiologistsand manufacturers.
As a 23-year-old engineer, Yao introduced diagnostic ultrasoundto China in 1962 after founding SIUI to apply ultrasound technologyto nondestructive testing and medical applications. He designedChina's first A-mode scanner for human medical use in 1963 anddeveloped an M-mode scanner in 1970. A B-mode system, featuringa computer processor and electronic scanning capabilities, wasreleased in 1980. That system incorporated technologies licensedfrom Hitachi Medical Systems of Japan.
The institute, based in Shantou, near Hong Kong in Guangdongprovince, employs 500 workers. About 500 of the 2500 ultrasoundsystems built by SIUI in 1994 were exported, Yao said. The instituteis also a major manufacturer of linear, convex and mechanicalsector probes, he said.
SIUI's technology transfer agreement with Hitachi expired in1992, giving the institute the right to market SIUI-built productsindependently in the world market, Yao said. SIUI has sold scannersin Latin American and European markets for several years and hasopened a U.S. sales office in San Jose, CA.
Yao expressed satisfaction with his first RSNA experience."We were very successful here," he said. "We madea lot of contacts and have seen a lot of sales interest. We arelooking forward to being here next year."
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.